FDA Relaxes Vaccine Storage Rules to Speed Up Rollout

February 26, 2021 by Daniel Mollenkamp
Empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination center at the University of Nevada, Las Vegas in Las Vegas. (AP Photo/John Locher)

WASHINGTON – The Food and Drug Administration has relaxed the rules around storage and transportation for some coronavirus vaccines in order to speed up the vaccine rollout.

Frozen vials of Pfizer-BioNTech’s coronavirus vaccine will be allowed to be kept at “conventional temperatures” found in pharmaceutical freezers for up to two weeks, following data provided to the agency by the company. Typically, the FDA demands that undiluted vials be stored in an ultra-low temperature freezer between -80ºC to -60ºC (-112ºF to -76ºF), a written statement from the agency said. 

This will allow for more flexibility, according to the FDA. Health care providers will receive new fact sheets to reflect this update.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said that the data Pfizer provided to the agency proves that the vaccines will remain stable at these less extreme temperatures for the two-week time period.

“The alternative temperature for transportation and storage will help ease the burden of procuring ultra-low cold storage equipment for vaccination sites and should help to get vaccines to more sites,” Marks said in a written comment.

In the U.S., 68.27 million doses of the vaccine were administered as of Thursday, Feb. 25, according to data estimates affiliated with Oxford University. An estimated 13.8% of the country, or 46.07 million people, have received at least one dose of a coronavirus vaccine. 

The Pfizer vaccine got an emergency authorization from the FDA in December. An estimate provided by the Department of Health and Human Services reported that the U.S. had purchased about $6 billion worth of Pfizer’s coronavirus vaccine as of Feb. 11.

The FDA has relaxed restrictions and oversights during the coronavirus, which has caused researchers to warn that the situation will need to be revisited after the coronavirus crisis is over to avoid the risk of weakening patient safety in the country. At the moment, however, vaccine rollout is a top priority for the agency.

Health

Virginia Expands COVID-19 Vaccine Eligibility to All Adults
In The States
Virginia Expands COVID-19 Vaccine Eligibility to All Adults
April 16, 2021
by TWN Staff

RICHMOND -- The Commonwealth of Virginia is expanding eligibility to get a COVID-19 vaccine to anyone 16 or older, beginning Sunday. The expansion of eligibility comes as Virginia reaches a new milestone in its vaccination program— approximately half of all adults in the Commonwealth have received... Read More

Disease Experts Look to the End Of Pandemic But Aren't Sure When
Health
Disease Experts Look to the End Of Pandemic But Aren't Sure When
April 16, 2021
by Tom Ramstack

WASHINGTON -- As the U.S. death toll reached 564,000 from COVID-19, the nation’s top disease experts said Thursday normal life will return for Americans only when enough of them get vaccinated. But with more than 70,000 new infections daily, they could not predict for Congress when... Read More

Material Hardship Can Cause  Adverse Health Outcomes in Young Adults
Political News
Material Hardship Can Cause Adverse Health Outcomes in Young Adults
April 15, 2021
by Alexa Hornbeck

An Urban Institute survey covering the first year of the coronavirus pandemic found that despite a steep drop in employment, the share of young adults reporting food insecurity or problems paying utility and medical bills actually declined compared to previous studies.  “Measures of hardship look at... Read More

J&J Vaccine to Remain in Limbo While Officials Seek Evidence
Health
J&J Vaccine to Remain in Limbo While Officials Seek Evidence

Johnson & Johnson's COVID-19 vaccine will remain in limbo for a while longer after government health advisers declared Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot — and if so, how big the risk... Read More

Biden Says Pause on J&J Shots Shows Gov't Putting Safety 1st
Health
Biden Says Pause on J&J Shots Shows Gov't Putting Safety 1st

WASHINGTON (AP) — President Joe Biden's COVID-19 vaccination campaign hit a snag when federal regulators recommended a "pause" in administering Johnson & Johnson shots. But the White House portrayed the action as important validation of his measured approach throughout the rollout. Biden declared Tuesday that even... Read More

Spoleto Festival USA Resuming In Charleson
Arts
Spoleto Festival USA Resuming In Charleson
April 13, 2021
by Dan McCue

CHARLESTON, S.C. - Charleston, S.C., is known for many things.  Southern charm.  Restaurants. Idyllic, Sun-soaked days. Being home to one of the nation’s busiest and most successful ports. But perhaps nothing brings more visitors to the city and the surrounding Lowcountry than the annual Spoleto Festival... Read More

News From The Well
scroll top